Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas.
Au
Wing-Yan
WY
Tam
Sidney
S
Fong
Bonnie M W
BM
Wan
Thomas S K
TS
Yip
Sze-Fai
SF
Kwong
Yok-Lam
YL
D000368:Aged; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D019337:Hematologic Neoplasms / Q000139:chemically induced*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*
D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide